Increased Serum and Musculotendinous Fibrogenic Proteins following Persistent Low-Grade Inflammation in a Rat Model of Long-Term Upper Extremity Overuse

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gao, Helen G L ^a   Fisher, Paul W ^a   Lambi, Alex G ^a   Wade, Christine K ^b   Barr Gillespie, Ann E ^c   Popoff, Steven N ^a   Barbe, Mary F ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c PACIFIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE; GELATINASE A; HYDROXYPROLINE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PLATELET DERIVED GROWTH FACTOR AB; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EPITENDON THICKENING; EVOKED MUSCLE RESPONSE; FEMALE; FIBROBLAST; FIBROSIS; FLEXOR DIGITORUM MUSCLE; FORCE; FOREARM; GRIP STRENGTH; HIGH REPETITION LOW FORCE; IMMUNOPATHOGENESIS; IMMUNOREACTIVITY; LIMB; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCULOTENDINOUS INFLAMMATION; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RAT; SERUM; SEX DIFFERENCE; TASK PERFORMANCE; TENDINITIS; TENDON; THICKNESS; TRAINING;

ANIMALS; CONNECTIVE TISSUE GROWTH FACTOR; CUMULATIVE TRAUMA DISORDERS; FEMALE; FORELIMB; INFLAMMATION MEDIATORS; INTERLEUKINS; MATRIX METALLOPROTEINASE 2; MUSCLE STRENGTH; MUSCLE, SKELETAL; PROTO-ONCOGENE PROTEINS C-SIS; RATS; RATS, SPRAGUE-DAWLEY; TENDONS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883198054     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071875     Document Type: Article

References (91)

1. Bureau of Labor Statistics (2012) Nonfatal ocupational injuries and illnesses requiring days away from work, 2011. http://www.bls.gov/news.release/osh2.nr0.htm. News Release USDL-12-2204, November 8, 2012. Accessed 16 July 2013.
2. Carp SJ, Barbe MF, Winter KA, Amin M, Barr AE, (2007) Inflammatory biomarkers increase with severity of upper-extremity overuse disorders. Clin Sci (Lond) 112: 305-314.
3. Rechardt M, Shiri R, Matikainen S, Viikari-Juntura E, Karppinen J, et al. (2011) Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders. Cytokine 54: 149-153.
4. Riondino S, La Farina F, Martini F, Guadagni F, Ferroni P, (2011) Functional impairment in video terminal operators is related to low-grade inflammation. International archives of occupational and environmental health 84: 745-751.
5. Dennett X, Fry HJ, (1988) Overuse syndrome: a muscle biopsy study. Lancet 1: 905-908.
6. Rempel DM, Diao E, (2004) Entrapment neuropathies: pathophysiology and pathogenesis. J Electromyogr Kinesiol 14: 71-75.
7. Hirata H, Nagakura T, Tsujii M, Morita A, Fujisawa K, et al. (2004) The relationship of VEGF and PGE2 expression to extracellular matrix remodelling of the tenosynovium in the carpal tunnel syndrome. J Pathol 204: 605-612.
8. Barbe MF, Barr AE, (2006) Inflammation and the pathophysiology of work-related musculoskeletal disorders. Brain Behav Immun 20: 423-429.
9. Barr AE, Barbe MF, Clark BD, (2004) Systemic inflammatory mediators contribute to widespread effects in work-related musculoskeletal disorders. Exerc Sport Sci Rev 32: 135-142.
10. Barr AE, Barbe MF, Clark BD, (2004) Work-related musculoskeletal disorders of the hand and wrist: epidemiology, pathophysiology, and sensorimotor changes. J Orthop Sports Phys Ther 34: 610-627.
11. Freeland AE, Tucci MA, Barbieri RA, Angel MF, Nick TG, (2002) Biochemical evaluation of serum and flexor tenosynovium in carpal tunnel syndrome. Microsurgery 22: 378-385.
12. Larsson B, Bjork J, Elert J, Lindman R, Gerdle B, (2001) Fibre type proportion and fibre size in trapezius muscle biopsies from cleaners with and without myalgia and its correlation with ragged red fibres, cytochrome-c-oxidase-negative fibres, biomechanical output, perception of fatigue, and surface electromyography during repetitive forward flexions. Eur J Appl Physiol 84: 492-502.
13. Uchio Y, Ochi M, Ryoke K, Sakai Y, Ito Y, et al. (2002) Expression of neuropeptides and cytokines at the extensor carpi radialis brevis muscle origin. J Shoulder Elbow Surg 11: 570-575.
14. Kelly M, Kolb M, Bonniaud P, Gauldie J, (2003) Re-evaluation of fibrogenic cytokines in lung fibrosis. Curr Pharm Des 9: 39-49.
15. Thrall RS, Vogel SN, Evans R, Shultz LD, (1997) Role of tumor necrosis factor-alpha in the spontaneous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol 151: 1303-1310.
16. Phan SH, Gharaee-Kermani M, McGarry B, Kunkel SL, Wolber FW, (1992) Regulation of rat pulmonary artery endothelial cell transforming growth factor-beta production by IL-1 beta and tumor necrosis factor-alpha. J Immunol 149: 103-106.
17. Phan SH, Kunkel SL, (1992) Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18: 29-43.
18. Liu JY, Sime PJ, Wu T, Warshamana GS, Pociask D, et al. (2001) Transforming growth factor-beta(1) overexpression in tumor necrosis factor-alpha receptor knockout mice induces fibroproliferative lung disease. Am J Respir Cell Mol Biol 25: 3-7.
19. Steinman RA, Robinson AR, Feghali-Bostwick CA, (2012) Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts. PLoS One 7: e48560.
20. Kuiper JI, van Dieen JH, Everts V, Verbeek JH, Frings-Dresen MH, (2004) Associations between serum markers of collagen metabolism and spinal shrinkage. Clin Biomech (Bristol, Avon) 19: 209-212.
21. Kuiper JI, Verbeek JH, Everts V, Straub JP, Frings-Dresen MH, (2005) Serum markers of collagen metabolism: construction workers compared to sedentary workers. Occup Environ Med 62: 363-367.
22. Kuiper JI, Verbeek JH, Straub JP, Everts V, Frings-Dresen MH, (2002) Physical workload of student nurses and serum markers of collagen metabolism. Scand J Work Environ Health 28: 168-175.
23. Ettema AM, Amadio PC, Zhao C, Wold LE, An KN, (2004) A histological and immunohistochemical study of the subsynovial connective tissue in idiopathic carpal tunnel syndrome. J Bone Joint Surg Am 86-A: 1458-1466.
24. Hirata H, Tsujii M, Yoshida T, Imanaka-Yoshida K, Morita A, et al. (2005) MMP-2 expression is associated with rapidly proliferative arteriosclerosis in the flexor tenosynovium and pain severity in carpal tunnel syndrome. J Pathol 205: 443-450.
25. Ettema AM, Zhao C, An KN, Amadio PC, (2006) Comparative anatomy of the subsynovial connective tissue in the carpal tunnel of the rat, rabbit, dog, baboon, and human. Hand 1: 78-84.
26. Neuman MG, Schmilovitz-Weiss H, Hilzenrat N, Bourliere M, Marcellin P, et al. (2012) Markers of inflammation and fibrosis in alcoholic hepatitis and viral hepatitis C. Int J Hepatol 2012: 231210.
27. Phanish MK, Winn SK, Dockrell ME, (2010) Connective tissue growth factor-(CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114: e83-92.
28. Leask A, Parapuram SK, Shi-Wen X, Abraham DJ, (2009) Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? J Cell Commun Signal 3: 89-94.
29. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, et al. (1999) Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 181: 153-159.
30. Lipson KE, Wong C, Teng Y, Spong S, (2012) CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair 5 Suppl 1: S24.
31. Garner BC, Stoker AM, Kuroki K, Evans R, Cook CR, et al. (2011) Using animal models in osteoarthritis biomarker research. J Knee Surg 24: 251-264.
32. Pedersen SJ, Sorensen IJ, Garnero P, Johansen JS, Madsen OR, et al. (2011) ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFalpha inhibitors. Ann Rheum Dis 70: 1375-1381.
33. Pasternak B, Schepull T, Eliasson P, Aspenberg P, (2010) Elevation of systemic matrix metalloproteinases 2 and 7 and tissue inhibitor of metalloproteinase 2 in patients with a history of Achilles tendon rupture: pilot study. Br J Sports Med 44: 669-672.
34. Manns JM, Uknis AB, Rico MC, Agelan A, Castaneda J, et al. (2006) A peptide from thrombospondin 1 modulates experimental erosive arthritis by regulating connective tissue growth factor. Arthritis Rheum 54: 2415-2422.
35. Saxton JM, (2000) A review of current literature on physiological tests and soft tissue biomarkers applicable to work-related upper limb disorders. Occup Med (Lond) 50: 121-130.
36. Carp SJ, Barr AE, Barbe MF, (2008) Serum biomarkers as signals for risk and severity of work-related musculoskeletal injury. Biomark Med 2: 67-79.
37. Stauber WT, Smith CA, Miller GR, Stauber FD, (2000) Recovery from 6 weeks of repeated strain injury to rat soleus muscles. Muscle Nerve 23: 1819-1825.
38. Issa R, Zhou X, Constandinou CM, Fallowfield J, Millward-Sadler H, et al. (2004) Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking. Gastroenterology 126: 1795-1808.
39. Jarvinen MJ, Lehto MU, (1993) The effects of early mobilisation and immobilisation on the healing process following muscle injuries. Sports Med 15: 78-89.
40. Worrell TW, (1994) Factors associated with hamstring injuries. An approach to treatment and preventative measures. Sports Med 17: 338-345.
41. Barr AE, Barbe MF, (2002) Pathophysiological tissue changes associated with repetitive movement: a review of the evidence. Phys Ther 82: 173-187.
42. Barbe MF, Elliott MB, Abdelmagid SM, Amin M, Popoff SN, et al. (2008) Serum and tissue cytokines and chemokines increase with repetitive upper extremity tasks. J Orthop Sports Phys Ther 26: 1320-1326.
43. Barbe MF, Barr AE, Gorzelany I, Amin M, Gaughan JP, et al. (2003) Chronic repetitive reaching and grasping results in decreased motor performance and widespread tissue responses in a rat model of MSD. J Orthop Res 21: 167-176.
44. Coq JO, Barr AE, Strata F, Russier M, Kietrys DM, et al. (2009) Peripheral and central changes combine to induce motor behavioral deficits in a moderate repetition task. Exp Neurol 220: 234-245.
45. Elliott MB, Barr AE, Kietrys DM, Al-Shatti T, Amin M, et al. (2008) Peripheral neuritis and increased spinal cord neurochemicals are induced in a model of repetitive motion injury with low force and repetition exposure. Brain Res 1218: 103-113.
46. Xin DL, Harris MY, Wade CK, Amin M, Barr AE, et al. (2011) Aging enhances serum cytokine response but not task-induced grip strength declines in a rat model of work-related musculoskeletal disorders. BMC Musculoskelet Disord 12: 63.
47. Abdelmagid SM, Barr AE, Rico M, Amin M, Litvin J, et al. (2012) Performance of repetitive tasks induces decreased grip strength and increased fibrogenic proteins in skeletal muscle: role of force and inflammation. PloS One 7: e38359.
48. Fedorczyk JM, Barr AE, Rani S, Gao HG, Amin M, et al. (2010) Exposure-dependent increases in IL-1beta, substance P, CTGF, and tendinosis in flexor digitorum tendons with upper extremity repetitive strain injury. J Orthop Res 28: 298-307.
49. Rani S, Barbe MF, Barr AE, Litivn J, (2010) Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping. J Cell Physiol 225: 152-167.
50. Gerr F, Marcus M, Ensor C, Kleinbaum D, Cohen S, et al. (2002) A prospective study of computer users: I. Study design and incidence of musculoskeletal symptoms and disorders. Am J Ind Med 41: 221-235.
51. Clark BD, Al-Shatti TA, Barr AE, Amin M, Barbe MF, (2004) Performance of a high-repetition, high-force task induces carpal tunnel syndrome in rats. J Orthop Sports Phys Ther 34: 244-253.
52. Cook JL, Kiss ZS, Khan KM, Purdam CR, Webster KE, (2004) Anthropometry, physical performance, and ultrasound patellar tendon abnormality in elite junior basketball players: a cross-sectional study. Br J Sports Med 38: 206-209.
53. Barr AE, Safadi FF, Gorzelany I, Amin M, Popoff SN, et al. (2003) Repetitive, negligible force reaching in rats induces pathological overloading of upper extremity bones. J Bone Miner Res 18: 2023-2032.
54. Gallagher S, Heberger JR, (2013) Examining the interaction of force and repetition on musculoskeletal disorder risk: a systematic literature review. Human Factors 55: 108-124.
55. Kietrys DM, Barr-Gillespie AE, Amin M, Wade CK, Popoff SN, et al. (2012) Aging contributes to inflammation in upper extremity tendons and declines in forelimb agility in a rat model of upper extremity overuse. PloS One 7: e46954.
56. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, et al. (2002) Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J 16: 1630-1632.
57. Barr AE, Barbe MF, (2004) Inflammation reduces physiological tissue tolerance in the development of work-related musculoskeletal disorders. J Electromyogr Kinesiol 14: 77-85.
58. Iyer SS, Cheng G, (2012) Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 32: 23-63.
59. Jana M, Dasgupta S, Saha RN, Liu X, Pahan K, (2003) Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages. J Neurochem 86: 519-528.
60. Pedersen BK, Febbraio MA, (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88: 1379-1406.
61. Rohde T, MacLean DA, Richter EA, Kiens B, Pedersen BK, (1997) Prolonged submaximal eccentric exercise is associated with increased levels of plasma IL-6. Am J Physiol 273: E85-91.
62. Tucci MA, Barbieri RA, Freeland AE, (1997) Biochemical and histological analysis of the flexor tenosynovium in patients with carpal tunnel syndrome. Biomed Sci Instrum 33: 246-251.
63. Kjaer M, (2004) Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol Rev 84: 649-698.
64. Heinemeier KM, Olesen JL, Haddad F, Langberg H, Kjaer M, et al. (2007) Expression of collagen and related growth factors in rat tendon and skeletal muscle in response to specific contraction types. J Physiol 582: 1303-1316.
65. Smith CA, Stauber F, Waters C, Alway SE, Stauber WT, (2007) Transforming growth factor-beta following skeletal muscle strain injury in rats. J Appl Physiol 102: 755-761.
66. Seher A, Nickel J, Mueller TD, Kneitz S, Gebhardt S, et al. (2011) Gene expression profiling of connective tissue growth factor (CTGF) stimulated primary human tenon fibroblasts reveals an inflammatory and wound healing response in vitro. Mol Vis 17: 53-62.
67. Hawinkels LJ, Ten Dijke P, (2011) Exploring anti-TGF-beta therapies in cancer and fibrosis. Growth Factors 29: 140-152.
68. Ihn H, (2008) Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis. J Dermatol Sci 49: 103-113.
69. Sato S, Hasegawa M, Takehara K, (2001) Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 27: 140-146.
70. Song JJ, Aswad R, Kanaan RA, Rico MC, Owen TA, et al. (2007) Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF-beta1 to induce mesenchymal cell condensation. J Cell Physiol 210: 398-410.
71. Clark BD, Barr AE, Safadi FF, Beitman L, Al-Shatti T, et al. (2003) Median nerve trauma in a rat model of work-related musculoskeletal disorder. J Neurotrauma 20: 681-695.
72. Grotendorst GR, (1997) Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev 8: 171-179.
73. Yu F, Chou CW, Chen CC, (2009) TNF-alpha suppressed TGF-beta-induced CTGF expression by switching the binding preference of p300 from Smad4 to p65. Cell Signal 21: 867-872.
74. Beddy D, Mulsow J, Watson RW, Fitzpatrick JM, O'Connell PR, (2006) Expression and regulation of connective tissue growth factor by transforming growth factor beta and tumour necrosis factor alpha in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg 93: 1290-1296.
75. Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, et al. (2003) Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol 163: 2043-2052.
76. van Nieuwenhoven FA, Jensen LJ, Flyvbjerg A, Goldschmeding R, (2005) Imbalance of growth factor signalling in diabetic kidney disease: is connective tissue growth factor (CTGF, CCN2) the perfect intervention point? Nephrol Dial Transplant 20: 6-10.
77. Andrae J, Gallini R, Betsholtz C, (2008) Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22: 1276-1312.
78. Heldin CH, Westermark B, (1999) Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316.
79. Heuchel R, Berg A, Tallquist M, Ahlen K, Reed RK, et al. (1999) Platelet-derived growth factor beta receptor regulates interstitial fluid homeostasis through phosphatidylinositol-3′ kinase signaling. Proc Natl Acad Sci U S A 96: 11410-11415.
80. De Mello Malheiro OC, Giacomini CT, Justulin LA Jr, Delella FK, Dal-Pai-Silva M, et al. (2009) Calcaneal tendon regions exhibit different MMP-2 activation after vertical jumping and treadmill running. Anat Rec 292: 1656-1662.
81. Pap G, Eberhardt R, Sturmer I, Machner A, Schwarzberg H, et al. (1998) Development of osteoarthritis in the knee joints of Wistar rats after strenuous running exercise in a running wheel by intracranial self-stimulation. Pathol Res Pract 194: 41-47.
82. Kamekura S, Hoshi K, Shimoaka T, Chung U, Chikuda H, et al. (2005) Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13: 632-641.
83. Droppelmann CA, Gutierrez J, Vial C, Brandan E, (2009) Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin. J Biol Chem 284: 13551-13561.
84. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev14: 163-176.
85. Kehl LJ, Fairbanks CA, (2003) Experimental animal models of muscle pain and analgesia. Exerc Sport Sci Rev 31: 188-194.
86. Baker BA, Mercer RR, Geronilla KB, Kashon ML, Miller GR, et al. (2007) Impact of repetition number on muscle performance and histological response. Med Sci Sports Exerc 39: 1275-1281.
87. Li YP, Reid MB, (2001) Effect of tumor necrosis factor-alpha on skeletal muscle metabolism. Curr Opin Rheumatol 13: 483-487.
88. Rani S, Barbe MF, Barr AE, Litvin J, (2009) Induction of periostin-like factor and periostin in forearm muscle, tendon, and nerve in an animal model of work-related musculoskeletal disorder. J Histochem Cytochem 57: 1061-1073.
89. Graham KM, Singh R, Millman G, Malnassy G, Gatti F, et al. (2010) Excessive collagen accumulation in dystrophic (mdx) respiratory musculature is independent of enhanced activation of the NF-kappaB pathway. J Neurol Sci Jul 15;294 (1-2) ():: 43-50.
90. George J, Chandrakasan G, (2000) Biochemical abnormalities during the progression of hepatic fibrosis induced by dimethylnitrosamine. Clin Biochem Oct;33 (7) ():: 563-70.90.
91. Attallah AM, Toson EA, Shiha GE, Omran MM, Abdel-Aziz MM, et al. (2007) Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C. J Immunoassay Immunochem 2007;28 (3) ():: 199-211.